Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Selenium in the treatment of head and neck lymphedema.

Bruns F, Büntzel J, Mücke R, Schönekaes K, Kisters K, Micke O.

Med Princ Pract. 2004 Jul-Aug;13(4):185-90.

2.

Selenium in the treatment of radiation-associated secondary lymphedema.

Micke O, Bruns F, Mücke R, Schäfer U, Glatzel M, DeVries AF, Schönekaes K, Kisters K, Büntzel J.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):40-9.

PMID:
12694822
3.

Selenium substitution during radiotherapy of solid tumours - laboratory data from two observation studies in gynaecological and head and neck cancer patients.

Büntzel J, Micke O, Kisters K, Bruns F, Glatzel M, Schönekaes K, Kundt G, Schäfer U, Mücke R.

Anticancer Res. 2010 May;30(5):1783-6.

PMID:
20592379
4.

Reduction of postoperative lymphedema after oral tumor surgery with sodium selenite.

Zimmermann T, Leonhardt H, Kersting S, Albrecht S, Range U, Eckelt U.

Biol Trace Elem Res. 2005 Sep;106(3):193-203.

PMID:
16141467
5.

Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients.

Büntzel J, Riesenbeck D, Glatzel M, Berndt-Skorka R, Riedel T, Mücke R, Kisters K, Schönekaes KG, Schäfer U, Bruns F, Micke O.

Anticancer Res. 2010 May;30(5):1829-32.

PMID:
20592387
6.

Sodium selenite as prophylaxis against erysipelas in secondary lymphedema.

Kasseroller R.

Anticancer Res. 1998 May-Jun;18(3C):2227-30.

PMID:
9703790
7.
8.

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.

Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ.

Arch Otolaryngol Head Neck Surg. 2008 Oct;134(10):1060-5. doi: 10.1001/archotol.134.10.1060.

PMID:
18936351
9.

Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy.

McQuellon RP, Moose DB, Russell GB, Case LD, Greven K, Stevens M, Shaw EG.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1180-5.

PMID:
11955728
10.

Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and -IV carcinomas of the head and neck. Long-term results including functional outcome.

Huguenin P, Glanzmann C, Taussky D, Lütolf UM, Schmid S, Moe K.

Strahlenther Onkol. 1998 Aug;174(8):397-402.

PMID:
9739379
11.

Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.

Deng J, Murphy BA, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Gilbert J, Ridner SH.

Head Neck. 2013 Jul;35(7):1026-35. doi: 10.1002/hed.23084. Epub 2012 Jul 12.

12.

[Administration of selenium in lymphedema].

Kasseroller R.

Med Klin (Munich). 1997 Sep 15;92 Suppl 3:50-1. German.

PMID:
9417503
13.

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, Flentje M, Eckel HE, Mueller RP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1161-71. Erratum in: Int J Radiat Oncol Biol Phys 2001 Oct 1;51(2):569.

PMID:
11483325
14.

Selenium in oncology: from chemistry to clinics.

Micke O, Schomburg L, Buentzel J, Kisters K, Muecke R.

Molecules. 2009 Oct 12;14(10):3975-88. doi: 10.3390/molecules14103975. Review.

15.

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

Merlano M, Benasso M, Corvò R, Rosso R, Vitale V, Blengio F, Numico G, Margarino G, Bonelli L, Santi L.

J Natl Cancer Inst. 1996 May 1;88(9):583-9.

16.

Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.

Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.

Oncol Rep. 1998 Nov-Dec;5(6):1499-505.

PMID:
9769395
17.

Prevalence of secondary lymphedema in patients with head and neck cancer.

Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Murphy BA.

J Pain Symptom Manage. 2012 Feb;43(2):244-52. doi: 10.1016/j.jpainsymman.2011.03.019. Epub 2011 Jul 30.

PMID:
21802897
18.

Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.

Ling SM, Roach M 3rd, Fu KK, Coleman C, Chan A, Singer M.

Cancer J Sci Am. 1996 Nov-Dec;2(6):321-9.

PMID:
9166552
19.

Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.

Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):725-31.

PMID:
16199308
20.

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ.

J Clin Oncol. 2008 Aug 1;26(22):3770-6. doi: 10.1200/JCO.2007.14.6647.

Items per page

Supplemental Content

Write to the Help Desk